Patriot Financial Group Insurance Agency’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-23
Closed -$14K 1596
2022
Q2
$14K Sell
23
-16
-41% -$10.4K ﹤0.01% 1141
2022
Q1
$27K Buy
39
+13
+50% +$8.22K ﹤0.01% 979
2021
Q4
$16K Sell
26
-39
-60% -$24K ﹤0.01% 1311
2021
Q3
$39K Buy
65
+9
+16% +$5.59K 0.01% 955
2021
Q2
$31K Buy
56
+10
+22% +$5.07K 0.01% 1015
2021
Q1
$22K Sell
46
-30
-39% -$14.6K 0.01% 1050
2020
Q4
$37K Buy
76
+39
+105% +$21.1K 0.01% 780
2020
Q3
$21K Buy
37
+7
+23% +$4.24K 0.01% 784
2020
Q2
$19K Hold
30
0.01% 765
2020
Q1
$15K Hold
30
0.01% 737
2019
Q4
$11K Hold
30
﹤0.01% 825
2019
Q3
$8K Hold
30
﹤0.01% 850
2019
Q2
$9K Buy
+30
New +$9.99K ﹤0.01% 836
2018
Q2
Sell
-8
Closed -$3K 851
2018
Q1
$3K Hold
8
﹤0.01% 840
2017
Q4
$3K Hold
8
﹤0.01% 834
2017
Q3
$4K Hold
8
﹤0.01% 745
2017
Q2
$4K Hold
8
﹤0.01% 727
2017
Q1
$3K Hold
8
﹤0.01% 721
2016
Q4
$3K Buy
+8
New +$3.04K ﹤0.01% 650

Other funds holding REGN

Patriot Financial Group Insurance Agency's REGN Position: Q3 2022 in Review

Patriot Financial Group Insurance Agency sold out of Regeneron Pharmaceuticals (REGN) in Q3 2022, closing a stake of 23 shares — an estimated $14K sold.

Patriot Financial Group Insurance Agency first reported a position in REGN in Q4 2016 and held it in 19 quarters. The position peaked at $39K in Q3 2021. 1,081 funds tracked by Wall St. Rank hold REGN as of Q3 2022.

  • Patriot Financial Group Insurance Agency reported no remaining Regeneron Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 23 Regeneron Pharmaceuticals shares in Q3 2022, an estimated $14K.
  • Patriot Financial Group Insurance Agency first reported a position in Regeneron Pharmaceuticals in Q4 2016 and held it in 19 quarters.
  • Patriot Financial Group Insurance Agency's Regeneron Pharmaceuticals position peaked at $39K in Q3 2021.
  • 1,081 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2022.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q3 2022, filed 1 Nov 2022.